A mother can be told that exhaustion, swelling, shortness of breath, or a racing heart are simply part of pregnancy or new motherhood. Sometimes they are. But sometimes they are the first signals of a serious cardiac condition, including peripartum cardiomyopathy (PPCM). The future maternal cardiac screening conversation begins with a simple, life-saving belief: symptoms deserve to be heard, investigated, and never brushed aside.

Pregnancy places extraordinary demands on the heart. Blood volume rises, heart rate changes, fluid shifts, and the body works constantly to support both mother and baby. That is why maternal heart disease can be difficult to spot. The warning signs may look familiar at first, especially during the exhausting weeks before and after delivery. The cost of missing those signs, however, can be devastating.

Why maternal heart screening needs to change

PPCM is a form of heart failure that can develop during the last month of pregnancy or in the months after birth. It weakens the heart muscle, making it harder for the heart to pump blood effectively. While PPCM is uncommon, it is serious, and delayed diagnosis can lead to severe complications.

The challenge is not that every pregnant or postpartum woman needs the same test at the same time. The challenge is that the current system too often waits until symptoms become impossible to ignore. A mother may visit urgent care, call an obstetric office, or mention her concerns at a routine appointment and still be reassured without a fuller cardiac evaluation.

Future screening must be built around earlier recognition, clear follow-up, and respect for maternal intuition. It should make room for the woman who says, “Something does not feel right,” even when her symptoms do not fit a neat checklist.

What future maternal cardiac screening could look like

The future is unlikely to be one universal test for every mother. A more realistic and compassionate approach combines risk assessment, symptom screening, timely testing, and connected care between obstetric and cardiac teams.

A heart-health conversation early in pregnancy

Screening can start before a symptom appears. At prenatal visits, care teams can ask about personal and family history of heart disease, high blood pressure, cardiomyopathy, prior pregnancy complications, diabetes, autoimmune conditions, and blood clotting concerns. They can also ask about previous PPCM or a family history of unexplained heart failure.

This information matters because risk is not evenly distributed. Some mothers will benefit from closer monitoring because of known heart conditions or prior complications. Others may have no obvious risk factors at all, which is why risk assessment cannot replace attention to symptoms.

Better symptom checks before and after birth

A quick question about whether a mother is “doing okay” is not enough. Meaningful screening uses specific questions: Is she short of breath while resting or lying flat? Does she wake up gasping for air? Has swelling in her feet, ankles, legs, or abdomen worsened suddenly? Is her heart racing, skipping beats, or pounding? Is she unusually weak, dizzy, faint, or experiencing chest pressure?

These symptoms do not automatically mean PPCM. They can have other causes, some less serious and some urgent. But they should trigger thoughtful clinical evaluation, particularly when they are new, worsening, or paired with rapid weight gain, persistent cough, or inability to perform normal daily activities.

The postpartum period deserves special attention. Too often, maternal care becomes fragmented after delivery, even though PPCM can arise after a baby is born. Future screening should treat postpartum recovery as an active period of cardiac observation, not a time when mothers are expected to simply push through discomfort.

Smarter use of BNP testing and cardiac evaluation

BNP, or B-type natriuretic peptide, is a blood test that can help clinicians assess whether the heart is under strain. It is not a stand-alone diagnosis for PPCM, and it is not appropriate as a substitute for a full medical evaluation. Still, when symptoms raise concern for heart failure, BNP testing may help a care team decide whether urgent cardiac assessment is needed.

Used alongside a physical exam, blood pressure assessment, electrocardiogram, imaging such as an echocardiogram, and a patient’s symptom history, BNP can be one valuable piece of the picture. The goal is not to turn every worried moment into unnecessary testing. The goal is to give clinicians practical tools to distinguish normal recovery from warning signs that need faster attention.

A future-focused system would make these pathways clearer. A postpartum patient with concerning shortness of breath should not have to wonder whether to call her obstetrician, primary care provider, or emergency department. Care teams need shared protocols that move mothers quickly toward the right evaluation.

Technology can help, but listening comes first

Remote blood pressure monitoring, virtual postpartum check-ins, wearable heart-rate data, and electronic symptom questionnaires may expand access to care. These tools could be especially helpful for mothers who live far from specialists, lack transportation, or are recovering while caring for a newborn.

But technology has limits. A normal-looking number cannot erase a mother’s lived experience, and an app cannot replace a clinician who listens. Data should support human care, not become another barrier a mother must overcome to be believed.

The best future maternal cardiac screening model will use technology to flag risk and speed communication while preserving what matters most: a clear conversation, careful examination, and prompt referral when something feels wrong.

Equity must be part of early detection

Maternal cardiac safety is also an equity issue. Black women in the United States face disproportionately high rates of maternal mortality and are more likely to have concerns minimized or care delayed. Any meaningful screening strategy must confront those realities directly.

That means consistent standards across hospitals and clinics, accessible postpartum follow-up, language-appropriate education, and care that is free from assumptions about pain, stress, body size, age, or socioeconomic status. It also means making sure mothers know the warning signs before they leave the hospital, not only after a crisis begins.

Screening works only when people can access the next step. Identifying risk without timely cardiology care, insurance support, transportation, or postpartum follow-up leaves families carrying the burden alone. Earlier detection must be paired with real pathways to treatment.

The role families and advocates can play

Mothers are often focused on everyone else. Partners, relatives, friends, doulas, and support networks may be the first to notice that she cannot catch her breath, is sleeping upright, looks unusually swollen, or seems far more exhausted than expected. Loving someone postpartum includes taking her symptoms seriously.

If warning signs are severe or sudden, especially chest pain, fainting, severe trouble breathing, confusion, or blue or gray lips, seek emergency care immediately. For persistent or worsening symptoms that feel concerning, encourage prompt contact with a medical professional and ask directly whether a cardiac evaluation is needed.

Advocacy also happens before an emergency. Sharing PPCM awareness, asking whether a care setting has postpartum warning-sign education, and supporting organizations that promote early detection all help make maternal heart health more visible. At HeartMomsPPCM, every conversation about PPCM and BNP testing carries the same message: mothers deserve to be protected, believed, and cared for.

The future of maternal cardiac screening will be shaped not only by better tests, but by a higher standard of listening. When a mother says her body feels different, let that be the beginning of care, not the end of the conversation.